Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells ; volume:12 ; number:6 ; day:16 ; month:11 ; year:2010 ; pages:1-15 ; date:12.2010
Breast cancer research ; 12, Heft 6 (16.11.2010), 1-15, 12.2010
- Creator
-
Jin, Quanri
- Contributor
-
Yuan, Linda X.
Boulbes, Delphine
Baek, Jong Min
Wang, Ying Nai
Gomez-Cabello, Daniel
Hawke, David H.
Yeung, Sai Ching
Lee, Mong Hong
Hortobagyi, Gabriel N.
Hung, Mien Chie
Esteva, Francisco J.
SpringerLink (Online service)
- DOI
-
10.1186/bcr2777
- URN
-
urn:nbn:de:1111-201603249064
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jin, Quanri
- Yuan, Linda X.
- Boulbes, Delphine
- Baek, Jong Min
- Wang, Ying Nai
- Gomez-Cabello, Daniel
- Hawke, David H.
- Yeung, Sai Ching
- Lee, Mong Hong
- Hortobagyi, Gabriel N.
- Hung, Mien Chie
- Esteva, Francisco J.
- SpringerLink (Online service)
Other Objects (12)
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Regulation of endothelial nitric oxide synthase by phosphorylation
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Loss of fatty acid synthase inhibits the “HER2-PI3K/Akt axis” activity and malignant phenotype of Caco-2 cells
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Regulation of endothelial nitric oxide synthase by phosphorylation
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Loss of fatty acid synthase inhibits the “HER2-PI3K/Akt axis” activity and malignant phenotype of Caco-2 cells
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Regulation of endothelial nitric oxide synthase by phosphorylation
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines